1. Lavender Rose Investment Ltd. (Lavender Rose), & 2. Morning Brook Investment Ltd. (Morning Brook)
CCIC-2021/01/806
A compact analysis
This page shows the compact analysis of this judgement. The full analysis — procedural history, issue-by-issue holdings with ratio and obiter, advocates, and paragraph-level evidence for every claim — is being added to the record in batches and will appear here when this judgement has been through it.
¶1
SUMMARY UNDER REGULATION 13 (1A) OF THE COMPETITION COMMISSION OF INDIA (PROCEDURE IN REGARD TO THE TRANSACTION OF BUSINESS RELATING TO COMBINATIONS), REGULATIONS, 2011 (AS AMENDED)
¶2
I. Parties to the Combination
¶3
- The parties to the combination are—
¶4
- (a) Lavender Rose Investment Ltd ( Lavender Rose );
¶5
- (b) Morning Brook Investment Ltd ( Morning Brook );
¶6
- (c) MedPlus Health Services Private Limited ( MedPlus ); Optival Health Solutions Private Limited ( Optival ); (ii) MHS Pharmaceuticals Private Limited ( MHS Pharmaceuticals ); (iii) Nova Sud Pharmaceuticals Private Limited ( Nova ); (iv) Wynclark Pharmaceuticals Private Limited ( Wynclark ); (v) Kalyani Meditimes Private Limited ( Kalyani ); (vi) Deccan Medisales Private Limited ( Deccan ); (vii) Sidson Pharma Distributors Private Limited ( Sidson ); (viii) Shri Banashankari Pharma Private Limited ( Shri Banashankari ); (ix) Sai Sridhar Pharma Private Limited ( Sai Sridhar ); and (x) Venkatakrishna Enterprises Private Limited ( Venkatakrishna ).
¶7
(d) Agilemed Investments Private Limited ( Agilemed ).
¶8
- Lavender Rose and Morning Brook are referred to as the Acquirers . MedPlus, Optival, MHS Pharmaceuticals, Nova, Wynclark, Kalyani, Deccan, Sidson, Shri Banashankari, Sai Sridhar, Venkatakrishna and Agilemed are referred to as the Target Entities . The Acquirers and the Target Entities are collectively referred to as the Parties .
Similar cases
Judgements on the same questions, provisions and authorities, from every court